Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Human Molecular Genetics|February 8, 2017
RpA1 ameliorates symptoms of mutant ataxin-1 knock-in mice and enhances DNA damage repairJuliana Bosso Taniguchi, Kanoh Kondo, Kyota Fujita, et al.British Journal of Cancer|May 15, 2024
Synergistic antitumor activity by dual blockade of CCR1 and CXCR2 expressed on myeloid cells within the tumor microenvironmentHideyuki Masui, Kenji Kawada, Yoshiro Itatani, et al.Molecular and Clinical Oncology|January 10, 2022
Efficacy of side-to-end anastomosis to prevent anastomotic leakage after anterior resection for rectal cancerHirochika Kato, Takashi Ishida, Nobuhiro Nitori, et al.Human Molecular Genetics|February 8, 2017
Targeting TEAD/YAP-transcription-dependent necrosis, TRIAD, ameliorates Huntington's disease pathologyYing Mao, Xigui Chen, Min Xu, et al.Scientific Reports|August 26, 2016
HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer's diseaseKyota Fujita, Kazumi Motoki, Kazuhiko Tagawa, et al.Surgery Today|May 8, 2025
Use of a zipline skin closure device in gastroenterological surgery: a multicenter randomized controlled trial assessing wound infection incidence, operation time, and cosmesisAyato Obana, Takuya Minagawa, Ayako Shimada, et al.The Journal of Cell Biology|May 5, 2010
Mutant huntingtin impairs Ku70-mediated DNA repairYasushi Enokido, Takuya Tamura, Hikaru Ito, et al.Scientific Reports|September 23, 2016
Identification of hepta-histidine as a candidate drug for Huntington's disease by in silico-in vitro- in vivo-integrated screens of chemical librariesTomomi Imamura, Kyota Fujita, Kazuhiko Tagawa, et al.Scientific Reports|December 14, 2023
Downregulation of osteoprotegerin in colorectal cancer cells promotes liver metastasis via activating tumor-associated macrophageWataru Hirata, Yoshiro Itatani, Hideyuki Masui, et al.Lung Cancer (Amsterdam, Netherlands)|April 28, 2024
Mirtazapine plus granisetron and dexamethasone for carboplatin-induced nausea and vomiting in patients with thoracic cancers: A prospective multicenter phase II trialHirotoshi Iihara, Masamichi Iwai, Ryo Morita, et al.Pageof 7